The State of the Science Lecture on Women and Heart Disease by Anne Rosenfeld of the Oregon Health Sciences University made it clear that there is much to learn about the ways the disease is unique to women. What we do know indicates that risk, symptoms, progression and treatment of CVD are all

The CARDIoGRAM consortium, of which the Heart Institute is a founding member, reported finding 13 new genetic regions associated with increased risk for coronary artery disease and heart attack. CARDIoGRAM brings together research teams from around the world to pool data sets and increase their

Following Burgon’s talk at the International Forum, Philip Devereaux of McMaster University spoke about Canada’s unique place in the world of cardiovascular medicine. Not only is cardiovascular disease (CVD) the leading cause of death globally but by 2020, the incidence in developing countries is

Coronary artery disease is an inflammatory condition characterized by plaque deposits, which can rupture, causing heart attack and stroke. The Holy Grail for researchers remains finding a way to non-invasively determine which plaques are at risk for rupture. Several graduate students discussed

Dr. Michel Le May, Director of the Heart Institute Regional STEMI Program, discussed the impact of bleeding on mortality in patients referred to primary percutaneous coronary intervention (PCI; angioplasty and stenting) through the STEMI heart attack program. Patients who had a major or minor

In a featured research presentation, surgical resident Dr. Joel Price discussed the use of a low-tech simulator to give trainee surgeons after-hours practice time to hone their technique. Surgical skills are usually learned directly on patients in the OR, but a variety of evolving issues are making